Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 – present)

Author： Landis-Piwowar Kristin Chen Di Foldes Robert Chan Tak-Hang Dou Qing Ping

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.2, 2013-02, pp. : 189-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novobiocin Analogs as Potential Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 9, 2017-05 ,pp. : 728-733

Bentham Science Publishers

Access to resources Recommend Favorite

Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010)

By Marzaro Giovanni Guiotto Adriano Chilin Adriana

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 223-252

Informa Healthcare

Access to resources Recommend Favorite

4-Aminoquinazoline Analogs: A Novel Class of Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-06 ,pp. : 1177-1194

Bentham Science Publishers

Access to resources Recommend Favorite

Hedgehog pathway inhibitors: a patent review (2009 – present)

By Hadden Matthew Kyle

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Novel thyrotropin-releasing hormone analogs: a patent review

By Khomane Kailas S Meena Chhuttan L Jain Rahul Bansal Arvind K

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1673-1691

Informa Healthcare

Access to resources Recommend Favorite